David Roby

ADMA BioCenters

ADMA BioCenters are FDA-licensed facilities dedicated to the collection of human plasma from donors. Human plasma is used to make special medications to help treat and prevent infections in patients. ADMA BioCenters operates as a wholly-owned subsidiary of our parent company ADMA Biologics, an end-to-end commercial biopharmaceutical company committed to manufacturing and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.